{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:47:39Z","timestamp":1794030459072,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"he Science and Technology Plan Project of Chongzuo City","award":["2025ZC0208"],"award-info":[{"award-number":["2025ZC0208"]}]},{"name":"the Guangxi Key Research and Development Project","award":["AB24010094"],"award-info":[{"award-number":["AB24010094"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260241"],"award-info":[{"award-number":["82260241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04849-x","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:08:14Z","timestamp":1774433294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of tirofiban in acute ischemic stroke patients with early neurological deterioration: a meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Rongxin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianquan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"10446","key":"4849_CR1","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung TW, De Leeuw F-E. Stroke. Lancet. 2024;403(10446):2820\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(24)00642-1.","journal-title":"Lancet"},{"issue":"5","key":"4849_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","volume":"22","author":"G Tsivgoulis","year":"2023","unstructured":"Tsivgoulis G, Katsanos AH, Sandset EC, Turc G, Nguyen TN, Bivard A, Fischer U, Khatri P. Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol. 2023;22(5):418\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(22)00519-1.","journal-title":"Lancet Neurol"},{"key":"4849_CR3","doi-asserted-by":"publisher","first-page":"128618","DOI":"10.1016\/j.ijbiomac.2023.128618","volume":"257","author":"Y Xu","year":"2024","unstructured":"Xu Y, Hu Y, Wu G, Niu L, Fang C, Li Y, Jiang L, Yuan C, Huang M. Specific inhibition on PAI-1 reduces the dose of alteplase for ischemic stroke treatment. Int J Biol Macromol. 2024;257:128618. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128618.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"4849_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/cns.14058","volume":"29","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ma H, Zhang Q, Jin F, Xu Y, Ma Q, Ji X. Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: experience from a single center. CNS Neurosci Ther. 2023;29(3):957\u201367. https:\/\/doi.org\/10.1111\/cns.14058.","journal-title":"CNS Neurosci Ther"},{"key":"4849_CR5","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.lanwpc.2022.100406","volume":"21","author":"Q Ye","year":"2022","unstructured":"Ye Q, Zhai F, Chao B, Cao L, Xu Y, Zhang P, Han H, Wang L, Xu B, Chen W, Wen C, Wang S, Wang R, Zhang L, Jiao L, Liu S, Zhu Y-C, Wang L-D. Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020. Lancet Reg Health - Western Pac. 2022;21:100406. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100406.","journal-title":"Lancet Reg Health - Western Pac"},{"issue":"26","key":"4849_CR6","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","volume":"389","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen W, Pan Y, Jing J, Wang C, Johnston SC, Amarenco P, Bath PM, Jiang L, Yang Y, Wang T, Han S, Meng X, Lin J, Zhao X, Liu L, Zhao J, Li Y, Zang Y, Wang Y. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med. 2023;389(26):2413\u201324. https:\/\/doi.org\/10.1056\/NEJMoa2309137.","journal-title":"N Engl J Med"},{"issue":"3","key":"4849_CR7","doi-asserted-by":"publisher","first-page":"e70343","DOI":"10.1111\/cns.70343","volume":"31","author":"S Cencer","year":"2025","unstructured":"Cencer S, Packard L, Davis A, Ahrar A, Miller M, Khan N, Wees N, Min J. Prevalence of aspirin or clopidogrel pharmacological resistance in ischemic stroke: a step toward precision medicine. CNS Neurosci Ther. 2025;31(3):e70343. https:\/\/doi.org\/10.1111\/cns.70343.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"4849_CR8","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/STROKEAHA.120.033551","volume":"52","author":"BH Baek","year":"2021","unstructured":"Baek BH, Yoon W, Lee YY, Kim SK, Kim J-T, Park MS. Intravenous tirofiban infusion after angioplasty and stenting in intracranial atherosclerotic stenosis-related stroke. Stroke. 2021;52(5):1601\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.120.033551.","journal-title":"Stroke"},{"issue":"10","key":"4849_CR9","doi-asserted-by":"publisher","first-page":"e16419","DOI":"10.1111\/ene.16419","volume":"31","author":"Z Sun","year":"2024","unstructured":"Sun Z, Huang S, Li W, Yang Y, Wu Y, Ma X, Nie X, Jin W, Liu C, Li X, Xu Y, Dong J, Liao Y, Sun B, Han W, Zhao Q, Chi H, Wang Y, Liu L, Zhang M. Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis. Eur J Neurol. 2024;31(10):e16419. https:\/\/doi.org\/10.1111\/ene.16419.","journal-title":"Eur J Neurol"},{"issue":"12","key":"4849_CR10","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1161\/STROKEAHA.117.019193","volume":"48","author":"W Zhao","year":"2017","unstructured":"Zhao W, Che R, Shang S, Wu C, Li C, Wu L, Chen J, Duan J, Song H, Zhang H, Ling F, Wang Y, Liebeskind D, Feng W, Ji X. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy. Stroke. 2017;48(12):3289\u201394. https:\/\/doi.org\/10.1161\/STROKEAHA.117.019193.","journal-title":"Stroke"},{"issue":"7","key":"4849_CR11","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA group. preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"issue":"3","key":"4849_CR12","doi-asserted-by":"publisher","first-page":"105459","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105459","volume":"30","author":"X Xie","year":"2021","unstructured":"Xie X, Xiao J, Wang Y, Pan L, Ma J, Deng L, Yang J, Ren L. Predictive model of early neurological deterioration in patients with acute ischemic stroke: a retrospective cohort study. J stroke Cerebrovasc diseases: official J Natl Stroke Association. 2021;30(3):105459. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105459.","journal-title":"J stroke Cerebrovasc diseases: official J Natl Stroke Association"},{"issue":"oct18 2","key":"4849_CR13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane statistical methods group. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928\u20135928. https:\/\/doi.org\/10.1136\/bmj.d5928. Cochrane Bias Methods Group.","journal-title":"BMJ"},{"issue":"9","key":"4849_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"4849_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/FJC.0000000000001077","volume":"78","author":"H Zhang","year":"2021","unstructured":"Zhang H, Lin F, Zhao Y, Chang W, Liu H, Yin J, Li L. Assessing the Efficacy and safety of tirofiban in combination with dual-antiplatelet therapy in progressive ischemic stroke patients. J Cardiovasc Pharmacol. 2021;78(3):448\u201352. https:\/\/doi.org\/10.1097\/FJC.0000000000001077.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"4849_CR16","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.26355\/eurrev_202203_28357","volume":"26","author":"N Du","year":"2022","unstructured":"Du N, Wang L-X, Liu Y-L, Yin X-L, Zhao J-S, Yang L. Effect of tirofiban in treating patients with progressive ischemic stroke. Eur Rev Med Pharmacol Sci. 2022;26(6):2098\u2013105. https:\/\/doi.org\/10.26355\/eurrev_202203_28357.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"4849_CR17","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","volume":"50","author":"C Wu","year":"2019","unstructured":"Wu C, Sun C, Wang L, Lian Y, Xie N, Huang S, Zhao W, Ren M, Wu D, Ding J, Song H, Wang Y, Ma Q, Ji X. Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis. Stroke. 2019;50(12):3481\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026240.","journal-title":"Stroke"},{"key":"4849_CR18","doi-asserted-by":"publisher","first-page":"982684","DOI":"10.3389\/fneur.2022.982684","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang J, Ma Z, Mu G, Liang D, Li Y, Qian X, Zhang L, Shen F, Zhang L, Yu J, Liu Y. Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis. Front Neurol. 2022;13:982684. https:\/\/doi.org\/10.3389\/fneur.2022.982684.","journal-title":"Front Neurol"},{"key":"4849_CR19","unstructured":"Lyu Y, Hao et al. Tirofiban in patients with re-occlusive ischemic stroke after intravenous thrombolysis with alteplase: an effectiveness and safety analysis[J]. Chin J Neuromedicine. 2021;vol.20(4): 350\u20135. https:\/\/rs.yiigle.com\/cmaid\/1319114."},{"issue":"12","key":"4849_CR20","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/jcpt.13816","volume":"47","author":"Y Du","year":"2022","unstructured":"Du Y, Li Y, Duan Z, Ma C, Wang H, Liu R, Li S, Lian Y. The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration. J Clin Pharm Ther. 2022;47(12):2350\u20139. https:\/\/doi.org\/10.1111\/jcpt.13816.","journal-title":"J Clin Pharm Ther"},{"key":"4849_CR21","doi-asserted-by":"publisher","unstructured":"Cheng X, Li H, Lv H, Wang L. Efficacy and safety of tirofiban for patients with early neurological deterioration after intravenous thrombolysis in treatment of acute cerebral infarction. Asian J Surg. 2024;S1015-9584(24):02218\u20138. https:\/\/doi.org\/10.1016\/j.asjsur.2024.09.173.\u00a0Advance online publication.","DOI":"10.1016\/j.asjsur.2024.09.173"},{"issue":"2","key":"4849_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3892\/ijmm.2021.5070","volume":"49","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review). Int J Mol Med. 2021;49(2):15. https:\/\/doi.org\/10.3892\/ijmm.2021.5070.","journal-title":"Int J Mol Med"},{"issue":"1","key":"4849_CR23","doi-asserted-by":"publisher","first-page":"16591","DOI":"10.1038\/s41598-024-67182-8","volume":"14","author":"V Perera","year":"2024","unstructured":"Perera V, Abelian G, Luettgen J, Aronson R, Li D, Wang Z, Zhang L, Lubin S, Merali S, Murthy B. Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and\/or clopidogrel in healthy participants. Sci Rep. 2024;14(1):16591. https:\/\/doi.org\/10.1038\/s41598-024-67182-8.","journal-title":"Sci Rep"},{"issue":"5","key":"4849_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","volume":"79","author":"M Yang","year":"2019","unstructured":"Yang M, Huo X, Miao Z, Wang Y. Platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban in acute ischemic stroke. Drugs. 2019;79(5):515\u201329. https:\/\/doi.org\/10.1007\/s40265-019-01078-0.","journal-title":"Drugs"},{"issue":"6","key":"4849_CR25","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/cns.14175","volume":"29","author":"Y Li","year":"2023","unstructured":"Li Y, Liu X, Chen S, Wang J, Pan C, Li G, Tang Z. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage. CNS Neurosci Ther. 2023;29(6):1484\u201396. https:\/\/doi.org\/10.1111\/cns.14175.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"4849_CR26","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1161\/STROKEAHA.119.027708","volume":"50","author":"JJ Warner","year":"2019","unstructured":"Warner JJ, Harrington RA, Sacco RL, Elkind MSV. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):3331\u20132. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027708.","journal-title":"Stroke"},{"issue":"6","key":"4849_CR27","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/svn-2023-002998","volume":"8","author":"L Liu","year":"2023","unstructured":"Liu L, Li Z, Zhou H, Duan W, Huo X, Xu W, Li S, Nie X, Liu H, Liu J, Sun D, Wei Y, Zhang G, Yuan W, Zheng L, Liu J, Wang D, Miao Z, Wang Y. Chinese stroke association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update. Stroke Vascular Neurol. 2023;8(6):e3. https:\/\/doi.org\/10.1136\/svn-2023-002998.","journal-title":"Stroke Vascular Neurol"},{"issue":"4","key":"4849_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","volume":"28","author":"J Liu","year":"2019","unstructured":"Liu J, Shi Q, Sun Y, He J, Yang B, Zhang C, Guo R. Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(4):1126\u201332. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.12.044.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"22","key":"4849_CR29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa2214299","volume":"388","author":"W Zi","year":"2023","unstructured":"Zi W, Song J, Kong W, Huang J, Guo C, He W, Yu Y, Zhang B, Geng W, Tan X, Tian Y, Liu Z, Cao M, Cheng D, Li B, Huang W, Liu J, Wang P, Yu Z, Yang Q. Tirofiban for stroke without large or medium-sized vessel occlusion. N Engl J Med. 2023;388(22):2025\u201336. https:\/\/doi.org\/10.1056\/NEJMoa2214299.","journal-title":"N Engl J Med"},{"key":"4849_CR30","doi-asserted-by":"publisher","first-page":"703258","DOI":"10.3389\/fneur.2021.703258","volume":"12","author":"JM Hong","year":"2021","unstructured":"Hong JM, Kim DS, Kim M. Hemorrhagic transformation after ischemic stroke: mechanisms and management. Front Neurol. 2021;12:703258. https:\/\/doi.org\/10.3389\/fneur.2021.703258.","journal-title":"Front Neurol"},{"issue":"3","key":"4849_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/joim.13425","volume":"291","author":"J Wass\u00e9lius","year":"2022","unstructured":"Wass\u00e9lius J, Arnberg F, Von Euler M, Wester P, Ullberg T. Endovascular thrombectomy for acute ischemic stroke. J Intern Med. 2022;291(3):303\u201316. https:\/\/doi.org\/10.1111\/joim.13425.","journal-title":"J Intern Med"},{"issue":"1","key":"4849_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ajh.10451","volume":"75","author":"VL Serebruany","year":"2004","unstructured":"Serebruany VL, Malinin AI, Eisert RM, Sane DC. Risk of bleeding complications with antiplatelet agents: Meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol. 2004;75(1):40\u20137. https:\/\/doi.org\/10.1002\/ajh.10451.","journal-title":"Am J Hematol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04849-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:31:38Z","timestamp":1777861898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04849-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4849"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04849-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}